Day: December 27, 2024

STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common stock and reduction in the total number of authorized shares of its common stock from 200,000,000 to 16,666,667 will be effective as of 5:00 p.m. Eastern Time on Monday, December 30, 2024. The Company’s common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on Tuesday, December 31, 2024. Following the reverse stock split, the Company’s common stock will continue to trade on the Nasdaq Capital Market under the symbol “CARA” with the new CUSIP number, 140755 208. The reverse stock split is part of the Company’s plan to regain compliance with the minimum bid price requirement...

Considering that during the shares buy-back process of INVL Baltic Real Estate (hereinafter – the Company), the Company acquired 61,721 shares for EUR 166,646.70 from the Company’s shareholders for which they were paid on 24 December 2024, the Company announces the data on shares issued by the Company as of 24 December 2024:Type of shares Number of shares and total voting rights granted by the issued shares, units Number of votes for the quorum of the General Shareholders Meeting, units Nominal value, EUR Total nominal Value and authorised capital, EUR Portion of the authorised capital, %Ordinary registered shares 8,061,414 7,953,934 1.45 11,689,050.30 100The person authorized to provide additional information: Real Estate Fund Manager of Management Company Vytautas Bakšinskas E-mail vy...

Company Announcement 27 December 2024 Announcement No. 38 NKT awarded two high-voltage projects under existing framework agreement with TenneT NKT has been awarded two turnkey projects in Germany under the existing multi-year framework agreement with TenneT. The projects are part of TenneT’s 2GW Program, which is considered one of the most ambitious infrastructure projects in the energy transition of Europe. TenneT, the Dutch-German transmission system operator, has selected NKT to provide 525 kV XLPE high-voltage direct current (HVDC) on- and offshore power cable systems for two projects under the existing framework agreement, which was announced in Company Announcement no. 14 of 5 May 2023. – We are thrilled to once again be selected as a key partner for TenneT’s ambitious 2GW Program. This confirms our strong partnership and NKT’s...

Utrecht, 27 December 2024 Aalberts N.V. has reached an agreement to acquire 100% of the shares of Paulo Products Company (Paulo), operating five facilities in the USA and one in Mexico, generating an annual revenue of approximately USD 105 million with 522 employees. Paulo is a provider of industrial heat treatment and related services that are critical to achieving strength, hardness, and other metallurgical properties required in various industrial applications. It is the largest privately owned thermal processing platform in North America providing solutions including heat treatment, brazing and metal finishing. Paulo serves attractive end markets like automotive, aerospace, defence and power generation. In line with our ‘thrive 2030’ strategy, this acquisition will strengthen our geographical footprint in the USA. By combining Paulo’s...

VYVDURA® now approved for at-home self-injection in Japan for both generalized myasthenia gravis and CIDP argenx’s VYVGART® and VYVDURA portfolio approved in Japan for three indications – first country globally with access across three indications December 27, 2024, 7:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved VYVDURA for adults with chronic inflammatory demyelinating polyneuropathy (CIDP). VYVDURA is approved for CIDP as a once weekly 30-to-90 second subcutaneous injection, which can be self-administered at home, and is the first and only neonatal Fc receptor (FcRn) blocker approved for the treatment...

Revolutionizing See-Through AR Glasses with Unmatched Brightness and a Compact, Outdoor-Ready Design TAINAN, Taiwan, Dec. 27, 2024 (GLOBE NEWSWIRE) — Himax Technologies, Inc. (“Himax” or “Company”) (Nasdaq: HIMX), an industry leader in fabless display driver ICs and other semiconductors, today announced it will present its next-generation, proprietary ultra luminous 400K nit Color Sequential Front-lit LCoS Microdisplay solution at CES 2025, the largest consumer electronics show in Las Vegas, U.S.A. from January 7 – 10, 2025. The unparalleled brightness of the LCoS solution reaffirms Himax’s market leadership in LCoS and its steadfast commitment to advancing AR applications, catering to the critical demands of leading tech innovators in AR technology. Himax’s proprietary Color Sequential Front-lit LCoS Microdisplay sets...

Wuxi, China, Dec. 26, 2024 (GLOBE NEWSWIRE) — Park Ha Biological Technology Co., Ltd. (the “Company”), a company focused on developing private skincare labels, direct skincare product sales, and franchise alliance promotions, today announced the pricing of its initial public offering (the “Offering”) of 1,200,000 ordinary shares at a public offering price of $4.00 per ordinary share. The ordinary shares have been approved for listing on the Nasdaq Capital Market and are expected to commence trading on December 27, 2024 under the ticker symbol “PHH.” The Company expects to receive aggregate gross proceeds of $4.8 million from the Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriters a 45-day option to purchase up to...

Castellum, Inc. Announces Proposed Public Offering of Common StockCastellum, Inc. (NYSE-American: CTM) (the “Company” or “Castellum”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it intends to offer and sell shares of its common stock in a public offering – http://castellumus.com/VIENNA, Va., Dec. 26, 2024 (GLOBE NEWSWIRE) — Castellum, Inc. (NYSE-American: CTM) (the “Company” or “Castellum”), a cybersecurity, electronic warfare, and software services company focused on the federal government, announces that it intends to offer and sell shares of its common stock in a public offering. Castellum is offering all of the shares of common stock. The Company initially intends to use the net proceeds of the offering for working capital and general corporate...